Clinical trial
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar…
NCT00158990 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00158990 |
|---|---|
| Title | Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression. |
| Official title | Triiodothyronine (T3) Supplementation in Bipolar and Unipolar Depression: A Random Assignment, Double Blind, Placebo-Controlled Study. |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depression, Bipolar Disorder, Unipolar Depression |
| Intervention type | Drug |
| Interventions | triiodothyronine, sertraline |
| Enrollment | 220 |
| Start date | Oct 1, 2002 |
| Completion | Jul 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 4, 2007 |
| Countries | Israel, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: